Here is how your smartphone could soon tell you if you have covid
Then nan definitely won't be scrolling on your phone
The future has apparently arrived - and soon enough, you could test yourself for covid-19 and other respiratory illnesses through your phone.
Brisbane-based scientists from ResAPP have created a smartphone technology that was initially intended to diagnose respiratory conditions such as pneumonia, asthma and bronchiolitis. Essentially, an artificial intelligence system that can analyse your coughs.
However during a recent preliminary trial, researchers found that their app correctly identified covid in 90 per cent of infections by highlighting a signature sound in the users' coughs. During their test of 741 subjects, they also found that their app exceeded the real world sensitivity of rapid antigen testing.
“We’ve been able to match coughs down to positive Covid-19 results. So we’ve found signatures in cough sounds that give us an indication of Covid,” said Dr Tony Keating, ResApp’s chief executive, in a statement.
However, if the patient is not exhibiting symptoms, then the app's accuracy drops to between 50 and 60 per cent.
The technology is already being used in Australia, Indonesia and Switzerland to identify common respiratory issues and has been trained using a database of 6,000 different coughs.
Their landmark work has caught the eye of vaccine manufacturer Pfizer, who has offered $100m AUS (approximately £75m) to buy the company and all its platforms. They have since agreed on a non-exclusive partnership, according to the Huffington Post and will collaborate on further covid research.
"Pfizer represents a huge opportunity to get this test into people’s hands,” Keating added.
Similar ideas are being bounced around at Cambridge, where a team is currently crowdsourcing cough recordings. Researchers from the Massachusetts Institute of Technology are also working on their own design which they claim spots 98.5 per cent of infections.
- Bill Gates is still warning the world of another pandemic
- WHO confirms two new Omicron sub-variants are under investigation
- People who have Covid in the last six months warned over blood clot risks